Keyphrases
Randomized Controlled Trial
100%
Amblyopia
100%
Dichoptic
100%
Digital Therapeutics
100%
Confidence Interval
50%
Treatment Group
50%
Visual Acuity
50%
United States
16%
Current Treatment
16%
Between-group
16%
Adverse Events
16%
Effective Treatment
16%
Patient Demographics
16%
Intention-to-treat
16%
Clinical Practice
16%
Serious Adverse Events
16%
Neurodevelopmental Disorders
16%
Efficacy Outcomes
16%
Residual Vision
16%
Interim Analysis
16%
Poor Adherence
16%
Randomized Phase III Trial
16%
Community Site
16%
Examiner
16%
Vision Deficits
16%
Alone Time
16%
Nursing and Health Professions
Amblyopia
100%
Confidence Interval
75%
Group Therapy
75%
Visual Acuity
75%
Adverse Event
50%
Spectacles
50%
Disease
25%
Clinical Practice
25%
Patient Population
25%
Intention to Treat Analysis
25%
Medicine and Dentistry
Randomized Controlled Trial
100%
Amblyopia
100%
Visual Acuity
75%
Group Therapy
75%
Adverse Event
50%
Patient Population
25%
Intention-to-Treat Analysis
25%
Interim Analysis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Amblyopia
100%
Adverse Event
50%
Disease
25%
Neuroscience
Randomized Controlled Trial
100%
Amblyopia
100%
Neurodevelopmental Disorder
25%